Analysis of Microbial Biofilms in Peripheral Venous Catheters and Their Implication in Infectious Risk

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHôpital NOVO

About this trial

Peripheral venous catheters (PVCs) are the most commonly used intravascular medical devices in healthcare establishments. Although essential in patient care, PVCs represent a significant risk factor for nosocomial infections, as shown by the results of the national prevalence survey. While the main pathophysiological mechanisms are known, the specific factors driving the transition from simple colonization to infection remain unclear. This project aims to identify the major factors involved in the occurrence of bacterial infections related to the colonization of peripheral venous catheters.

Eligibility criteria

Qualifiers

Patient hospitalized in a care unit of the NOVO hospital (Pontoise site)

Major patient for whom a peripheral venous catheter has been in place for at least 2 days and at most 7 days, with or without signs of inflammation

Disqualifiers

Antibiotic treatment by any route

Patient with viral hepatitis, or human immunodeficiency virus (HIV) or suspected epidemic and biological risk (EBR)

Patient unable to understand and give non-opposition to study participation

Patient under guardianship

Trial design

Treatments tested in this trial

  • Inflammatory catheters: catheter removed because of infection at insertion site
  • Non-inflammatory catheters: catheter removed because it is no longer relevant to keep it in place

Treatment groups

250 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Hôpital NOVO

Lead sponsor

Université de Cergy Pontoise

Collaborator